These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26279022)

  • 1. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
    Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
    Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
    Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
    Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
    Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
    Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
    Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.
    Jensen AD; Nikoghosyan AV; Lossner K; Herfarth KK; Debus J; Münter MW
    BMC Cancer; 2012 May; 12():163. PubMed ID: 22551422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.
    Duprez F; Madani I; Morbée L; Bonte K; Deron P; Domján V; Boterberg T; De Gersem W; De Neve W
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):252-9. PubMed ID: 22027259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.
    Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Herfarth KK; Münter MW
    Radiat Oncol; 2011 Nov; 6():149. PubMed ID: 22046954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
    Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas.
    Schulz-Ertner D; Nikoghosyan A; Jäkel O; Haberer T; Kraft G; Scholz M; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):391-8. PubMed ID: 12738314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
    Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
    Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
    Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
    Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinus.
    Mohr A; Chaudhri N; Hassel JC; Federspil PA; Vanoni V; Debus J; Jensen AD
    Head Neck; 2016 Apr; 38 Suppl 1():E1445-51. PubMed ID: 26560744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
    Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.
    Jensen AD; Nikoghosyan A; Windemuth-Kieselbach C; Debus J; Münter MW
    BMC Cancer; 2010 Oct; 10():546. PubMed ID: 20937120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.